---
title: "Weekly Recap | AMRX.US +2.68%, most brokers rate it buy"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300854635.md"
description: "AMRX.US rose 2.68% this week to close at $20.30, while the S&P 500 slipped 0.27%, leaving the stock about 2.95 percentage points ahead of the benchmark. Trading was choppy: Monday opened lower and closed at $20.50, Tuesday hit a weekly high of $20.78 before pulling back, and Wednesday and Thursday drifted lower. Friday regained $20.30. Weekly amplitude was 6.93%, with active turnover—average daily volume ran about 69% above the median."
datetime: "2026-10-03T08:30:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300854635.md)
  - [en](https://longbridge.com/en/news/300854635.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300854635.md)
generator: "portal-rs"
---

# Weekly Recap | AMRX.US +2.68%, most brokers rate it buy

## The Week

AMRX.US rose 2.68% this week to close at $20.30, while the S&P 500 slipped 0.27%, leaving the stock about 2.95 percentage points ahead of the benchmark. Trading was choppy: Monday opened lower and closed at $20.50, Tuesday hit a weekly high of $20.78 before pulling back, and Wednesday and Thursday drifted lower. Friday regained $20.30. Weekly amplitude was 6.93%, with active turnover—average daily volume ran about 69% above the median. No major catalyst emerged this week; the stock largely consolidated around the $20 area.

## Analyst Ratings

Of the 7 analysts covering the stock, 4 rate it buy and 3 rate it overweight, with no hold, underweight or sell ratings. The consensus rating is strong buy, with a consensus target of $22.71, about 11.9% above the current price. Targets range from $20.00 to $27.00, showing moderate dispersion. The stock ranks 72nd out of 203 in its industry.

## The Week Ahead

Macro data dominates next week’s calendar: S&P Global services PMI final and ISM non-manufacturing PMI land on Monday (ISM prior 55.4, forecast 55), trade balance data follows on Tuesday, and EIA crude inventories on Wednesday. For a stock without company-specific events, shifts in overall risk appetite tied to these releases are the main thing to watch.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [AMRX.US](https://longbridge.com/en/quote/AMRX.US.md)

## Related News & Research

- [Signature Wealth Management Partners LLC Purchases 232,426 Shares of Amneal Pharmaceuticals, Inc. $AMRX](https://longbridge.com/en/news/302693007.md)
- [741,577 Amneal Pharmaceuticals, Inc. $AMRX Shares Acquired by Congress Asset Management Co.](https://longbridge.com/en/news/301110449.md)
- [Workers replaced by AI face difficulties finding new employment and often fall into AI's next hunting ground.](https://longbridge.com/en/news/303854832.md)
- [Tempus AI Earnings Ahead: Is TEM Set Up To Pop or Drop?](https://longbridge.com/en/news/303867113.md)
- [Bokf Na Purchases 20,274 Shares of The Estee Lauder Companies Inc. $EL](https://longbridge.com/en/news/303850728.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**